| TVR | tonic vibratory reflex; total vascular resistance; tricuspid valve replacement |
|---|---|
| VR | right arm [electrode]; valve replacement; variable ratio; vascular resistance; venous reflux; venous... |
| THRA | Total Hip Replacement Arthroplasty |
| TKRA | Total Knee Replacement Arthroplasty |
| ARF | Acute Renal Failure |
| split renal function test | A study performed to determine various functional parameters of one kidney compared to the contralateral kidney; ureteral catheters are inserted at cystoscopy into the ureter or renal pelvis bilaterally, and simultaneous measurements are made of urine flow rate, insulin, or PAH (if infused), endogenous creatinine, or various urinary solutes. Synonym: differential renal function test, split renal function test. (05 Mar 2000) |
|---|---|
| differential renal function test | A study performed to determine various functional parameters of one kidney compared to the contralateral kidney; ureteral catheters are inserted at cystoscopy into the ureter or renal pelvis bilaterally, and simultaneous measurements are made of urine flow rate, insulin, or PAH (if infused), endogenous creatinine, or various urinary solutes. Synonym: differential renal function test, split renal function test. (05 Mar 2000) |
| osteopetrosis with renal tubular acidosis | <syndrome> An inherited deficiency of carbonic anhydrase II that results in osteopetrosis and metabolic acidosis. Synonym: osteopetrosis with renal tubular acidosis. (05 Mar 2000) |
| effective renal blood flow | The amount of blood flowing to the parts of the kidney that are involved with production of constituents of urine. (05 Mar 2000) |
| effective renal plasma flow | <physiology> The amount of plasma flowing to the parts of the kidney that have a function in the production of constituents of urine; the clearance of substances such as iodopyracet and p-aminohippuric acid, assuming that the extraction ratio in the peritubular capillaries is 100%. It is the amount of plasma perfusing the kidney tubules per unit time, generally measured by p-aminohippurate clearance. It should be differentiated from renal plasma flow which is approximately 10% greater than the effective renal plasma flow. (07 Mar 2000) |
| end-stage renal disease | <nephrology> A patient with inadequate renal function to support life. Individuals with end-stage disease must rely in kidney dialysis or peritoneal dialysis to survive. End-stage renal disease may be caused by a number of problems including diabetes, sickle cell disease, hypertension and congenital renal disease (polycystic kidney disease). (27 Sep 1997) |
| tuberculosis, renal | Infection of the kidney with species of mycobacterium. (12 Dec 1998) |
| fatty renal capsule | The perirenal fat. Synonym: capsula adiposa renis, adipose capsule. (05 Mar 2000) |
| ureteric branches of the renal artery | <anatomy, artery> Supplies ureteric (renal) pelvis and superior portion of ureter. Synonym: rami ureterici arteriae renalis. (05 Mar 2000) |
| filling defect in renal collecting system | <radiology> Common causes: transitional cell carcinoma, blood clot, lucent calculus (urate) less common causes: fungus ball, sloughed papilla, fibroepithelial polyp, invasion by hypernephroma, malakoplakia, vessel impression, metastases (12 Dec 1998) |
| acupuncture therapy | Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. Heat or moxibustion and acupressure may be used in conjunction. (12 Dec 1998) |
| adjuvant therapy | <oncology, pharmacology> Treatment that is added to increase the effectiveness of a primary treatment. In cancer, adjuvant treatment usually refers to chemotherapy, hormonal therapy or radiation therapy after surgery to increase the likelihood of killing all cancer cells. (14 May 1997) |
| alternative therapy | A term given to nonconventional therapy usually given by persons who do not have a medical qualification. (16 Dec 1997) |
| analytic therapy | Short term for psychoanalytic therapy. (05 Mar 2000) |
| Antibody Directed Enzyme Prodrug Therapy | <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately. The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects. Acronym: ADEPT (14 Nov 1997) |